BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33606367)

  • 1. Tumor Necrotic Debris and High Nuclear Grade: Newly Identified High-risk Factors for Early-stage Endocervical Adenocarcinoma.
    Holloway SB; Colon GR; Zheng W; Lea JS
    Am J Clin Oncol; 2021 Apr; 44(4):162-168. PubMed ID: 33606367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumoral Morphologic Features From Cervical Biopsies That Are Predictive of a Negligible Risk for Nodal Metastasis and Tumor Recurrence in Usual-type Cervical Adenocarcinomas: A Multi-institutional Study.
    Wang Y; Chang RJ; Luo RZ; Yu J; Zhang X; Yang X; Quddus MR; Li L; Yang W; Liu A; Jiang Q; Zhao R; Zhu H; Zhou F; Wang Y; Sheng X; Liu LL; Wen YL; Banet N; Sung CJ; Qi Y; Bi R; Li M; Wang Y; Li J; Lin W; Wang Y; Rivera G; Chen H; Holloway SB; Fadare O; Liu J; Wang J; Lea J; Kong B; Zheng W
    Am J Surg Pathol; 2022 May; 46(5):713-724. PubMed ID: 34753864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FIGO 2018 stage IB endocervical adenocarcinomas: an international study of outcomes informed by prognostic biomarkers.
    Stolnicu S; Boros M; Hoang L; Almadani N; de Brot L; Baiocchi G; Bonvolim G; Parra-Herran C; Lerias S; Felix A; Roma A; Pesci A; Oliva E; Park K; Soslow RA; Abu-Rustum NR
    Int J Gynecol Cancer; 2021 Feb; 31(2):177-184. PubMed ID: 33177150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do FIGO stage IA and small (≤2 cm) IB1 cervical adenocarcinomas have a good prognosis and warrant less radical surgery?
    Al-Kalbani M; McVeigh G; Nagar H; McCluggage WG
    Int J Gynecol Cancer; 2012 Feb; 22(2):291-5. PubMed ID: 22080884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical correlation of lymphovascular invasion and Silva pattern of invasion in early-stage endocervical adenocarcinoma: proposed binary Silva classification system.
    Stolnicu S; Hoang L; Almadani N; De Brot L; Baiocchi G; Bovolim G; Brito MJ; Karpathiou G; Ieni A; Guerra E; Kiyokawa T; Dundr P; Parra-Herran C; Lérias S; Felix A; Roma A; Pesci A; Oliva E; Park KJ; Soslow RA; Abu-Rustum NR
    Pathology; 2022 Aug; 54(5):548-554. PubMed ID: 35501168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grading of endocervical adenocarcinoma: a novel prognostic system based on tumor budding and cell cluster size.
    Shi H; Ye L; Lu W; Lu B
    Mod Pathol; 2022 Apr; 35(4):524-532. PubMed ID: 34593968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns and risk factors of recurrence in low-risk early-stage cervical adenocarcinoma treated with surgery alone: implications on risk group stratification.
    Bae BK; Cho WK; Kim BG; Choi CH; Kim TJ; Lee YY; Lee JW; Park W
    Int J Gynecol Cancer; 2022 Dec; 32(12):1524-1530. PubMed ID: 36368708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral lymphatic vessel density and clinicopathologic features of patients with early-stage cervical cancer after radical hysterectomy.
    Zaganelli FL; Carvalho FM; Almeida BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho JP
    Int J Gynecol Cancer; 2010 Oct; 20(7):1225-31. PubMed ID: 21135594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative Conization and Risk of Recurrence in Patients Undergoing Laparoscopic Radical Hysterectomy for Early Stage Cervical Cancer: A Multicenter Study.
    Casarin J; Bogani G; Papadia A; Ditto A; Pinelli C; Garzon S; Donadello N; Laganà AS; Cromi A; Mueller M; Raspagliesi F; Ghezzi F
    J Minim Invasive Gynecol; 2021 Jan; 28(1):117-123. PubMed ID: 32320800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early cervical adenocarcinoma: selection criteria for radical surgery.
    Schorge JO; Lee KR; Lee SJ; Flynn CE; Goodman A; Sheets EE
    Obstet Gynecol; 1999 Sep; 94(3):386-90. PubMed ID: 10472864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservative treatment of stage IA1 adenocarcinoma of the uterine cervix with a long-term follow-up.
    Yahata T; Nishino K; Kashima K; Sekine M; Fujita K; Sasagawa M; Honma S; Kodama S; Tanaka K
    Int J Gynecol Cancer; 2010 Aug; 20(6):1063-6. PubMed ID: 20683418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
    dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
    Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic relevance of low-grade versus high-grade FIGO IB1 squamous cell uterine cervical carcinomas.
    Horn LC; Höhn AK; Hentschel B; Fischer U; Bilek K; Brambs CE
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):457-462. PubMed ID: 30603900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
    Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
    Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New pattern-based personalized risk stratification system for endocervical adenocarcinoma with important clinical implications and surgical outcome.
    Roma AA; Mistretta TA; Diaz De Vivar A; Park KJ; Alvarado-Cabrero I; Rasty G; Chanona-Vilchis JG; Mikami Y; Hong SR; Teramoto N; Ali-Fehmi R; Barbuto D; Rutgers JK; Silva EG
    Gynecol Oncol; 2016 Apr; 141(1):36-42. PubMed ID: 27016227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the revisited, revised, and expanded Silva pattern system for Chinese endocervical adenocarcinoma patients.
    Wang W; Song G; Lin J; Zheng X; Wang Y; Liu Y; Liu C
    Hum Pathol; 2019 Feb; 84():35-43. PubMed ID: 30218754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a difference in survival for IA1 and IA2 adenocarcinoma of the uterine cervix?
    Smith HO; Qualls CR; Romero AA; Webb JC; Dorin MH; Padilla LA; Key CR
    Gynecol Oncol; 2002 May; 85(2):229-41. PubMed ID: 11972381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
    Singh P; Tripcony L; Nicklin J
    Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When Does Neoadjuvant Chemotherapy Really Avoid Radiotherapy? Clinical Predictors of Adjuvant Radiotherapy in Cervical Cancer.
    Papadia A; Bellati F; Bogani G; Ditto A; Martinelli F; Lorusso D; Donfrancesco C; Gasparri ML; Raspagliesi F
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S944-51. PubMed ID: 26268452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of recurrence following laparoscopic radical hysterectomy for early-stage cervical cancer: A multi-institutional study.
    Casarin J; Buda A; Bogani G; Fanfani F; Papadia A; Ceccaroni M; Malzoni M; Pellegrino A; Ferrari F; Greggi S; Uccella S; Pinelli C; Cromi A; Ditto A; Di Martino G; Anchora LP; Falcone F; Bonfiglio F; Odicino F; Mueller M; Scambia G; Raspagliesi F; Landoni F; Ghezzi F
    Gynecol Oncol; 2020 Oct; 159(1):164-170. PubMed ID: 32665147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.